India Stocks / AMBUJACEM

Ambuja Cements Limited

AMBUJACEM · Basic Materials

About Ambuja Cements Limited (AMBUJACEM)

Ambuja Cements Limited is a Building Materials company operating in the Basic Materials sector. The company is headquartered in Ahmedabad, India. AMBUJACEM has been publicly traded since 2002, giving it 24+ years of trading history.

Ambuja Cements Limited (AMBUJACEM) has been publicly traded since 2002, making it a 24-year-old public company. It operates in the Building Materials industry within the Basic Materials sector. The company is headquartered in Ahmedabad, India and employs approximately 3,883 people. With a market capitalization of $1.1 trillion, AMBUJACEM is one of the largest publicly traded companies.

AMBUJACEM trades on the Indian stock exchanges (NSE/BSE) and is classified as a mega-cap-cap stock with a market capitalization of approximately $1.1 trillion. The company employs approximately 3,883 people worldwide.

Sector
Basic Materials
Industry
Building Materials
Headquarters
Ahmedabad, India
IPO Year
2002

Key Statistics

Current Price
₹425.35
Market Cap
₹1.05T
52-Week High
₹624.95
52-Week Low
₹424.40
Sector
Basic Materials
Industry
Building Materials

AMBUJACEM Investment Performance

AMBUJACEM has declined 23.6% year-to-date in 2026. Over the past 5 years, a $1,000 investment in AMBUJACEM would have grown to $1,632, representing a 63.2% total return. Since its IPO in 2002, a $1,000 investment would now be worth $24,071.

₹1,000 Invested in Ambuja Cements Limited (AMBUJACEM)

1 Year
₹854
+-15%
3 Years
₹1,222
+22%
5 Years
₹1,632
+63%
10 Years
₹2,406
+141%
Since IPO
₹24,071
+2307%

How much would ₹1,000 invested in AMBUJACEM be worth today?

What would ₹1,000 invested in AMBUJACEM 1 year ago be worth today?

A ₹1,000 investment in Ambuja Cements Limited (AMBUJACEM) in 2025 would be worth ₹854 as of May 2026, representing a -14.6% total return.

What would ₹1,000 invested in AMBUJACEM 3 years ago be worth today?

A ₹1,000 investment in Ambuja Cements Limited (AMBUJACEM) in 2023 would be worth ₹1,222 as of May 2026, representing a +22.2% total return.

What would ₹1,000 invested in AMBUJACEM 5 years ago be worth today?

A ₹1,000 investment in Ambuja Cements Limited (AMBUJACEM) in 2021 would be worth ₹1,632 as of May 2026, representing a +63.2% total return.

What would ₹1,000 invested in AMBUJACEM 10 years ago be worth today?

A ₹1,000 investment in Ambuja Cements Limited (AMBUJACEM) in 2016 would be worth ₹2,406 as of May 2026, representing a +140.6% total return.

What would ₹1,000 invested in AMBUJACEM at IPO be worth today?

A ₹1,000 investment in Ambuja Cements Limited (AMBUJACEM) at IPO would be worth ₹24,071 as of May 2026, representing a +2307.1% total return.

Monthly Returns Heatmap

Avg Monthly Return
+1.59%
Positive Months
170
60% of 284
Negative Months
113
40% of 284
Data Period
23+ years
284 months
Best Performers
Best month ever: Dec 2008 (+34.2%)
Best month on avg: July (+5.2%)
Worst Performers
Worst month ever: Mar 2020 (-24.1%)
Worst month on avg: January (-2.1%)

Over the past 23+ years (284 months), Ambuja Cements Limited (AMBUJACEM) has averaged a monthly return of +1.59% with a median return of +1.15%. The stock had 170 positive months (60%) and 113 negative months (40%). The best month in AMBUJACEM's history was December 2008 with a +34.2% return, while the worst was March 2020 at -24.1%. Historically, July tends to be the strongest month (averaging +5.2%), and January the weakest (-2.1%).

AMBUJACEM's longest winning streak was 9 consecutive months of gains, while its longest losing streak was 4 consecutive months of losses. The best full year was 2003 with a cumulative return of +69.0%, and the worst was 2008 at -56.9%.

Annual Returns

Over 24 years of trading history, Ambuja Cements Limited (AMBUJACEM) has delivered an average annual return of +20.26% with a median return of +19.59%. The compound annual growth rate (CAGR) is +15.31%. The stock posted gains in 17 years (71%) and losses in 7 years (29%).

AMBUJACEM's best year was 2003 with a +92.41% gain, while the worst was 2008 at -51.30%. The longest streak of consecutive positive years was 5, and the longest losing streak was 2 years. AMBUJACEM achieved double-digit gains (10%+) in 13 years. It suffered double-digit losses in 5 years.

Avg Return
+20.26%
Best Year
2003 (+92.41%)
Worst Year
2008 (-51.30%)
Positive Years
17/24
Year Return Start End
2026 -23.55% ₹556.35 ₹425.35
2025 +4.22% ₹533.85 ₹556.35
2024 +3.17% ₹517.44 ₹533.85
2023 -0.03% ₹517.60 ₹517.44
2022 +41.79% ₹365.05 ₹517.60
2021 +52.24% ₹239.79 ₹365.05
2020 +36.71% ₹175.40 ₹239.79
2019 -12.20% ₹199.77 ₹175.40
2018 -16.55% ₹239.39 ₹199.77
2017 +33.37% ₹179.49 ₹239.39
2016 +2.84% ₹174.54 ₹179.49
2015 -11.27% ₹196.72 ₹174.54
2014 +28.15% ₹153.50 ₹196.72
2013 -7.27% ₹165.54 ₹153.50
2012 +31.70% ₹125.69 ₹165.54
2011 +11.04% ₹113.19 ₹125.69
2010 +40.34% ₹80.65 ₹113.19
2009 +54.91% ₹52.06 ₹80.65
2008 -51.30% ₹106.91 ₹52.06
2007 +6.95% ₹99.96 ₹106.91
2006 +80.21% ₹55.47 ₹99.96
2005 +52.18% ₹36.45 ₹55.47
2004 +36.13% ₹26.78 ₹36.45
2003 +92.41% ₹13.92 ₹26.78

AMBUJACEM Investment Analysis: Valuation, Risk & Dividends

Key factors to consider when evaluating Ambuja Cements Limited as an investment

Valuation

AMBUJACEM currently trades at a trailing P/E ratio of 28.4, which is considered high relative to the broader market. The forward P/E of 24.5 suggests analysts expect earnings to be lower in the coming year. The price-to-book ratio stands at 1.9. The price-to-sales ratio is 2.7.

Dividends

Ambuja Cements Limited pays a dividend to shareholders with a current yield of 0.47%. This translates to $2.00 per share annually. The payout ratio of 13% indicates sustainable dividend coverage.

Risk & Volatility

AMBUJACEM has a beta of -0.17, indicating it is less volatile than the overall market. The stock's 52-week range is $424.40 to $624.95, and it currently trades near its 52-week low.

Analyst Ratings

Based on 41 analyst opinions, AMBUJACEM has a consensus "buy" rating. The average price target of $610.07 suggests 43.4% upside from current levels.

Frequently Asked Questions: AMBUJACEM

What sector is AMBUJACEM in?

AMBUJACEM operates in the Basic Materials sector, specifically in the Building Materials industry.

How has AMBUJACEM performed historically?

Over 24 years of trading history, AMBUJACEM has posted gains in 17 years (71% of the time). The best year was 2003 with a +92.4% return. Past performance does not guarantee future results.

How can I invest in AMBUJACEM?

You can invest in AMBUJACEM through any brokerage account that offers access to Indian exchanges. Popular options include commission-free brokers like Fidelity, Charles Schwab, or Robinhood (US), or international brokers like Interactive Brokers. You can buy individual shares or invest through ETFs that hold AMBUJACEM.

Does AMBUJACEM pay dividends?

Ambuja Cements Limited pays a dividend to shareholders with a current yield of 0.47%. This translates to $2.00 per share annually. The payout ratio of 13% indicates sustainable dividend coverage.

What does Ambuja Cements Limited do?

Ambuja Cements Limited is a Building Materials company operating in the Basic Materials sector. The company is headquartered in Ahmedabad, India.

What sector is AMBUJACEM in?

AMBUJACEM operates in the Basic Materials sector, specifically in the Building Materials industry.

When did AMBUJACEM go public?

Ambuja Cements Limited went public in 2002, making it a 24-year-old public company as of 2026.

How much would $1,000 invested in AMBUJACEM 5 years ago be worth today?

A $1,000 investment in AMBUJACEM five years ago would be worth approximately $1,632 today, representing a 63.2% return.

Does AMBUJACEM pay dividends?

Yes, Ambuja Cements Limited pays a dividend with a current yield of 0.47%, which is $2.0 per share annually.

What is AMBUJACEM's market cap?

Ambuja Cements Limited has a market capitalization of $1.1 trillion, classifying it as a mega-cap company.

What is AMBUJACEM's P/E ratio?

AMBUJACEM has a trailing P/E ratio of 28.4 and a forward P/E of 24.5, which measures how much investors are paying per dollar of earnings.

Is AMBUJACEM a buy, hold, or sell?

Based on 41 opinions, AMBUJACEM has a consensus "buy" rating. The average price target is $610.07.

Last updated: 3/14/2026